Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Cholesterol-Lowering Drug Aids Diabetes
Uncategorized

Cholesterol-Lowering Drug Aids Diabetes

By medwebJun 1, 2002
Share
Facebook Twitter Email

June 20, 2002

Cholesterol-Lowering Drug Aids Diabetes

CHICAGO— Statins, drugs usually prescribed for high cholesterol, have been found to slow diabetes-related kidney damage, according to a Northwestern University research study published in the June 11 issue of the Proceedings of the National Academy of Science.

The study found that statins affect the activity of a protein responsible for controlling the cycle of cell growth and division rather than acting by lowering lipids, said lead authors Farhad R. Danesh, MD, assistant professor of nephrology, and Yashpal S. Kanwar, MD, Paul E. Steiner Professor of Pathology at The Feinberg School of Medicine.

This research shows that statins slow diabetes-related kidney damage through a new mechanism and illuminates a novel pathway involved in kidney damage, Drs. Danesh and Kanwar said.

Individuals with diabetes are unable to metabolize excess glucose. Resulting high levels of glucose can cause organ damage, particularly in nerve cells and cells in the retina and kidney, where they speed up the rate of cell division.

Using cells cultured from rat kidney, the authors first simulated the high glucose conditions of a diabetic’s kidney, then treated the cells with a statin and conducted tests to determine the proteins that were affected by the drug.

Co-investigators on the study were Mehran M. Sadeghi, Nail Amro, Carrie Phillips, Lixia Zeng and Sun Lin.

Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Comments are closed.

Latest News

Northwestern Simulation’s In Situ Training Tests Cardiac Arrest Response Teams

Sep 25, 2023

Investigating the Link Between Iron Deficiency and Regulation of Cell Growth

Sep 25, 2023

Feinberg Investigators Identify How a Residential Neighborhood Can Impact Health

Sep 22, 2023

Robert Lamb, Renowned Expert on Influenza Virus, Dies at 72

Sep 22, 2023

Bethany Ekesa, Associate Director of SPARC, Honored with Jean E. Shedd University Citizenship Award

Sep 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230914_NM461
20230914_NM644
20230914_NM345
20230914_NM444
20230914_NM464
20230914_NM520
20230914_NM673
20230914_NM641
20230914_NM612
20230914_NM608
20230914_NM602
20230914_NM597

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.